Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
27th week of 2017 patent applcation highlights part 10
Patent application number
Title
Published
20170189409
MEDICAL USE
2017-07-06
20170189410
Amino Compounds for Treatment of Complement Mediated Disorders
2017-07-06
20170189411
Compounds That Modulate Oxidative Stress
2017-07-06
20170189412
ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION
2017-07-06
20170189413
COMPOSITIONS AND TREATMENT FOR EYE DISEASES AND DISORDERS
2017-07-06
20170189414
CONTROLLED RELEASE DELIVERY SYSTEM FOR NASAL APPLICATIONS AND METHOD OF TREATMENT
2017-07-06
20170189415
OXYTOCIN RECEPTOR ANTAGONIST THERAPY IN THE LUTEAL PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES
2017-07-06
20170189416
PHARMACEUTICAL COMPOSITION FOR TREATING BREAST CANCER
2017-07-06
20170189417
PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL CANCER
2017-07-06
20170189418
PHARMACEUTICAL COMPOSITION FOR TREATING LUNG CANCER
2017-07-06
20170189419
PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE CANCER
2017-07-06
20170189420
OXYSTEROLS AND HEDGEHOG SIGNALING
2017-07-06
20170189421
Compositions and Methods for Suppressing Endometrial Proliferation
2017-07-06
20170189422
STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE
2017-07-06
20170189423
Medicinal Aerosol Formulations
2017-07-06
20170189424
FLUTICASONE FUROATE IN THE TREATMENT OF COPD
2017-07-06
20170189425
Cancer Drug and Uses
2017-07-06
20170189426
PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR
2017-07-06
20170189427
Topical Minocycline Compositions and Methods of Using the Same
2017-07-06
20170189428
Dialkyl-phosphinoyl-alkane (Dapa) compounds and compositions for treatment of lower gastrointestinal tract disorders
2017-07-06
20170189429
Treating Arrhythmia with Mitochondrial-Targeted Antioxidants
2017-07-06
20170189430
ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS
2017-07-06
20170189431
ANTICANCER AGENTS OF THE ANTHRACYCLIN FAMILY
2017-07-06
20170189432
PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES
2017-07-06
20170189433
NICOTINAMIDE RIBOSIDE ANALOGS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
2017-07-06
20170189434
NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES
2017-07-06
20170189435
COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE
2017-07-06
20170189436
ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
2017-07-06
20170189437
COMBINATION THERAPY WITH SGLT-2 INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS
2017-07-06
20170189438
DI- and Tri-Cationic Glycosylated Antitumor Ether Lipids, L-Gucosylated Gaels and Rhamnose-Linked Gaels as Cytotoxic Agents Against Epithelial Cancer Cells and Cancer Stem Cells
2017-07-06
20170189439
METHODS FOR TREATING HCV
2017-07-06
20170189440
METHODS FOR TREATING INSULIN RESISTANCE AND FOR SENSITIZING PATIENTS TO GLP1 AGONIST THERAPY
2017-07-06
20170189441
DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES AND PEPTIDE CONTAINING CONJUGATES
2017-07-06
20170189442
PEPTIDE NUCLEIC ACID OF SUBGROUP J AVIAN LEUKOSIS VIRUS AND USES THEREOF
2017-07-06
20170189443
COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND CONDITIONS EMPLOYING ORAL ADMINISTRATION OF SODIUM PENTOSAN POLYSULFATE AND OTHER PENTOSAN POLYSULFATE SALTS
2017-07-06
20170189444
POLYMERIC COMPOSITIONS AND RELATED SYSTEMS AND METHODS FOR REGULATING BIOLOGICAL HYDROGELS
2017-07-06
20170189445
XENON ASSOCIATED WITH AN NMDA RECEPTOR ANTAGONIST FOR CONTROLLING TUMOR PROLIFERATION IN THE CENTRAL NERVOUS SYSTEM
2017-07-06
20170189446
Emulsion of Carotenoids and Ocular Antioxidants
2017-07-06
20170189447
FORMULATION FOR INCREASING ENERGY
2017-07-06
20170189448
NOVEL MESENCHYMAL STEM CELL SURFACE MARKER
2017-07-06
20170189449
MESENCHYMAL STEM CELL PARTICLES
2017-07-06
20170189450
GENE CORRECTION OF SCID-RELATED GENES IN HEMATOPOIETIC STEM AND PROGENITOR CELLS
2017-07-06
20170189451
USE OF ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS IN TREATING FISTULA
2017-07-06
20170189452
USE OF ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS IN TREATING FISTULA
2017-07-06
20170189453
TRANSGENIC PIG ISLETS AND USES THEREOF FOR TREATING DIABETES
2017-07-06
20170189454
SYSTEMS AND METHODS FOR STORAGE AND DELIVERY OF AMMONIA OXIDIZING BACTERIA
2017-07-06
20170189455
PREVOTELLA HISTICOLA PREPARATIONS AND THE TREATMENT OF AUTOIMMUNE CONDITIONS
2017-07-06
20170189456
Bacteroides CECT 7771 and the Use Thereof in the Prevention and Treatment of Excess Weight, Obesity and Metabolic and Immunological Alterations
2017-07-06
20170189457
Probiotic Sports Nutrition Compositions
2017-07-06
20170189458
LACTIC ACID BACTERIAL IMMUNOPOTENTIATING ACTIVITY-INCREASING COMPOSITION AND METHOD FOR INCREASING IMMUNOPOTENTIATING ACTIVITY OF LACTIC ACID BACTERIA
2017-07-06
20170189459
NOVEL BACTERIOPHAGE AND COMPOSITION COMPRISING SAME
2017-07-06
20170189460
NOVEL BACTERIOPHAGE AND COMPOSITION COMPRISING SAME
2017-07-06
20170189461
METHOD OF PREPARING FERMENTED CRUDE EXTRACT HAVING ANGIOTENSIN CONVERTING ENZYME INHIBITING ACTIVITY
2017-07-06
20170189462
Method for Conducing Concentrated Cannabis Oil to Be Stable, Emulsifiable and Flavorless for Use in Hot Beverages and Resulting Powderized Cannabis Oil
2017-07-06
20170189463
Method for Conducing Concentrated Cannabis Oil to Be Stable, Emulsifiable and Flavorless for Use in Hot Beverages and Resulting Powderized Cannabis Oil
2017-07-06
20170189464
METHOD FOR PREPARING GINSENG POLYSACCHARIDE FOR IMMUNE STIMULATION AND GINSENG POLYSACCHARIDE FOR IMMUNE STIMULATION PREPARED THEREFROM
2017-07-06
20170189465
Anti Hallucination Drug
2017-07-06
20170189466
Compositions for the Treatment of Dermatological Conditions, Disorders or Diseases
2017-07-06
20170189467
METHODS AND COMPOSITIONS FOR ENHANCEMENT OF ABILITY TO CONCENTRATE
2017-07-06
20170189468
TISSUE REGENERATION PROMOTER
2017-07-06
20170189469
MEDICAL DEVICES
2017-07-06
20170189470
PEPTIDE AND PEPTIDOMIMETIC INHIBITORS
2017-07-06
20170189471
COMPOSITIONS AND METHODS FOR TREATING FIBROSIS
2017-07-06
20170189472
ANTI-BACTERIAL COMPOSITIONS FOR DRUG ADMINISTRATION
2017-07-06
20170189473
COMPOSITION FOR PREVENTING OR TREATING STAPHYLOCOCCUS AUREUS INFECTION
2017-07-06
20170189474
ANTIFUNGAL THERAPY FOR THE TREATMENT OF HIRSCHSPRUNG-ASSOCIATED ENTEROCOLITIS
2017-07-06
20170189475
COMBINATION PREPARATION COMPRISING A CYTOKINE ANTAGONIST AND CORTICOSTEROID
2017-07-06
20170189476
PD-L1 FUSION PROTEIN AND USE THEREOF
2017-07-06
20170189477
Methods and Compositions of P27KIP1 Transcriptional Modulators
2017-07-06
20170189478
HATCHING FLUID ENZYMES AND USES THEREOF
2017-07-06
20170189479
SYNDECAN-4 PROTEOLIPOSOMES FOR ENHANCED CUTANEOUS WOUND HEALING AND MINIMIZED INFLAMMATORY IMMUNE RESPONSE
2017-07-06
20170189480
NEW MEDICAL AGENTS AND USES THEREOF
2017-07-06
20170189481
USE OF PEPTIDES THAT BLOCK METADHERIN- SND1 INTERACTION AS TREATMENT FOR CANCER
2017-07-06
20170189482
MUTANT NGAL PROTEINS AND USES THEREOF
2017-07-06
20170189483
DIAGNOSTIC AND THERAPEUTIC USES OF GELSOLIN IN RENAL FAILURE
2017-07-06
20170189484
CEACAM5 PEPTIDES FOR CROHN'S DISEASE
2017-07-06
20170189485
MODULATION OF ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) AND USES THEREFOR
2017-07-06
20170189486
MODIFIED FGF-21 POLYPEPTIDES AND USES THEREOF
2017-07-06
20170189487
LYOPHILIZED FORMULATION OF HGF
2017-07-06
20170189488
CODON-OPTIMIZED RECOMBINANT PLASMID, METHOD OF STIMULATING PERIPHERAL NERVE REGENERATION, AND METHOD OF TREATING NERVE DAMAGE IN HUMANS
2017-07-06
20170189489
CARDIAC MUSCLE FUNCTION AND MANIPULATION
2017-07-06
20170189490
METHODS OF TREATING COGNITIVE IMPAIRMENT
2017-07-06
20170189491
COMPOSITION CONTAINING NEUROPEPTIDE Y FOR INHIBITING SIDE EFFECTS OF ANTICANCER AGENTS
2017-07-06
20170189492
Use of Ultrarapid Acting Insulin
2017-07-06
20170189493
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES
2017-07-06
20170189494
PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII
2017-07-06
20170189495
USE OF MICROPEROXIDASES FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA
2017-07-06
20170189496
USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
2017-07-06
20170189497
Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe Disease
2017-07-06
20170189498
MITRECIN A POLYPEPTIDE WITH ANTIMICROBIAL ACTIVITY
2017-07-06
20170189499
HEMOSTATIC COMPOSITIONS
2017-07-06
20170189500
USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERS
2017-07-06
20170189501
METHOD OF TREATMENT OF SCHIZOPHRENIFORM DISORDER
2017-07-06
20170189502
IMMUNIZATION PROTOCOL FOR DIRECTED EXPANSION AND MATURATION
2017-07-06
20170189503
PCSK9 VACCINE AND METHODS OF USING THE SAME
2017-07-06
20170189504
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
2017-07-06
20170189505
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
2017-07-06
20170189506
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
2017-07-06
20170189507
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
2017-07-06
20170189508
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
2017-07-06